Aastrom Biosciences Inc (NASDAQ:ASTM)

CAPS Rating: 1 out of 5

The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.

Recs

0
Player Avatar CarlosDK (< 20) Submitted: 11/9/2012 2:47:52 PM : Outperform Start Price: $28.80 ASTM Score: -11.48

falling wedge

Featured Broker Partners


Advertisement